Aims-To compare the numbers of alkaline phosphatase positive reticulum cells (AL-RC) and macrophages in bone marrow transplant (BMT) recipients with numbers in normal subjects and to look for correlations with clinical features. Methods-Sections of femoral marrow were obtained at necropsy from 18 BMT recipients and nine normal subjects who had died suddenly. AL-RC were visualised through their endogenous alkaline phosphatase activity. Macrophages were stained by an immunocytochemical technique using the antibody EBMI11 (CD68) and through their endogenous acid phosphatase activity. The numbers of stained cells were counted and expressed as a percentage of total nucleated cells. Results-In both sets of marrow tissue, more macrophages stained for CD68 than for acid phosphatase, indicating macrophage heterogeneity. The percentage value for CD68 positive macrophages was higher among the transplant recipients (p < 0-01). At least in part this was caused by a reduction in haemopoietic cell numbers. Percentage values for acid phosphatase and alkaline phosphatase positive cells did not differ between the two groups. To exclude the effect of changes in marrow cellularity, stromal cell ratios were compared. The AL-RC: CD68 and acid phosphatase:CD68 ratios were both lower in BMT recipients, indicating that after BMT either the absolute number of AL-RC and acid phosphatase cells decreases, or CD68 cells increase, or there is a combination of the two.
S A Dilly, C J Jagger, J P Sloane Abstract Aims-To compare the numbers of alkaline phosphatase positive reticulum cells (AL-RC) and macrophages in bone marrow transplant (BMT) recipients with numbers in normal subjects and to look for correlations with clinical features. Methods-Sections of femoral marrow were obtained at necropsy from 18 BMT recipients and nine normal subjects who had died suddenly. AL-RC were visualised through their endogenous alkaline phosphatase activity. Macrophages were stained by an immunocytochemical technique using the antibody EBMI11 (CD68) and through their endogenous acid phosphatase activity. The numbers of stained cells were counted and expressed as a percentage of total nucleated cells. Results-In both sets of marrow tissue, more macrophages stained for CD68 than for acid phosphatase, indicating macrophage heterogeneity. The percentage value for CD68 positive macrophages was higher among the transplant recipients (p < 0-01). At least in part this was caused by a reduction in haemopoietic cell numbers. Percentage values for acid phosphatase and alkaline phosphatase positive cells did not differ between the two groups. To exclude the effect of changes in marrow cellularity, stromal cell ratios were compared. The AL-RC: CD68 and acid phosphatase:CD68 ratios were both lower in BMT recipients, indicating that after BMT either the absolute number of AL-RC and acid phosphatase cells decreases, or CD68 cells increase, or there is a combination of the two. There was no correlation between the number of each cell type and cell dose given at transplantation, time after transplantation, presence of graft versus host disease or infection, marrow erythroid:myeloid ratio, or peripheral white cell count. The ratio of AL-RC to macrophages in our intact marrow was 0 43, considerably higher than that reported in cultured marrow. Allogeneic bone marrow transplantation (BMT) for malignant haematological disease is followed by a variable period of pancytopenia. This is a consequence of the treatment required to achieve remission, the pre-transplant conditioning to eliminate host marrow and reduce host immune defences, and the time taken for the donor marrow to proliferate. The clinical problems of graft versus host disease (GvHD) led to ideas of purging donor marrow of T cells to prevent this complication. Purged marrows, however, were more liable to graft failure, possibly due to the unopposed action of recipient T lymphocytes, and so enhanced pre-transplant conditioning was required. Now interest is focused on the use of growth factors to stimulate haemopoietic recovery after BMT.
In normal bone marrow haemopoietic growth factors are probably produced by some of the marrow stromal cells. Stromal cells consist of a mixture of adipocytes, endothelial cells, fibroblasts, macrophages and "reticular cells". Two cell types seem to be of particular importance. One is a macrophage commonly associated with erythroid precursors and the other is the alkaline phosphatase positive reticulum cell (AL-RC). AL-RC are generally dendritic in shape and closely associated with granulocytic precursors. They 
Methods
Upper femoral marrow was obtained at necropsy from 18 marrow recipients and nine non-transplant subjects who died suddenly. All tissues were taken within 24 hours of death. Some was formalin fixed for paraffin wax embedding and some was mounted on cork in OCT compound and snap frozen in isopentane and liquid nitrogen. Paraffin wax sections were cut at 3 ,um and stained with haematoxylin and eosin and for chloroacetate esterase and reticulin. Frozen sections were used for staining for endogenous alkaline phosphatase, endogenous acid phosphatase, and with an antibody against macrophages, detecting CD68, EBM/11 (Dakopatts),4 and anti-factor VIII related antigen (Dakopatts). Frozen sections were cut at 6,um, mounted on multispot slides, air-dried for 1 to 2 hours, fixed in acetone for 25 minutes, rinsed in TRIS-buffered saline (TBS), pH7-6, further fixed in paraformaldehyde-periodate-lysine solution at 4°C for 4 minutes and rinsed in TBS. For demonstration of endogenous alkaline phosphatase, the sections were then incubated in substrate using the substituted naphthol method with napthol-ASBI-phosphate and Fast Red TR for 20 minutes. For acid phosphatase, the pararosanolin hydrochloric acid method at pH4-8 was used. After rinsing in distilled water and counterstaining with Mayer's haematoxylin they were mounted in Apathy's medium. For immunocytochemical staining with EBM/1 1, primary antibody was applied for 1 hour, followed by goat anti-mouse secondary antibody (F(ab)2 (Sigma)) for 30 minutes, alkaline phosphatase antialkaline phosphatase (Dako) for 30 minutes, and then substrate as above, but including Levamisole to block endogenous activity. For antibody against factor VIII related antigen, alkaline phosphatase labelled secondary antibody was used (goat anti-rabbit whole molecule; Sigma). All antisera were diluted in 3% bovine serum albumin in TBS at pH 7-6; No correlation was detected.
Macrophages accounted for 32% (range = 10%-67%) by CD68 staining and 8-6% (range = 3-5%-12-6%) by acid phosphatase staining. The number of macrophages staining for CD68 was significantly higher than the number staining with acid phosphatase (p < 0O01), and this difference was more pronounced than in the normal marrows. The median number of AL-RC was 6-4% (range = 02%-14A4%). Both If the number of each cell type after BMT was compared with the value in normal subjects (fig 1) , CD68 positive macrophage numbers were increased (p < 0O01) after BMT; acid phosphatase positive cells and AL-RC numbers were not significantly different. After BMT there was an inverse correlation between marrow cellularity and the number of AL-RC or macrophages, whether identified by CD68 or acid phosphatase ( fig  2) . This partially relates to having to assess patients was acute myeloid leukaemia (AML). Previous work, using the same staining techniques, has shown that the number of bone marrow macrophages seems to be normal while AL-RC numbers are increased in patients with untreated AML.6 LTBMC evidence from patients treated for AML with the "Bart's III" induction regimen and consolidation chemotherapy of thioguanine and cyclophosphamide but no BMT, indicates abnormalities of the stromal cells.7 Patients in unmaintained complete remission, who had received no chemotherapy in the preceding five years, showed impaired granulocytemacrophage progenitor cell generation associated with a failure of the stromal cell cultures to grow to confluence (colony stimulating factors were not studied). Most patients in our study received transplantations in first remission for AML and so are clinically similar to the patients studied by Chang,7 although they had received chemotherapy within the previous five years. Other work on LTBMC-adherent cells8 showed high resistance to methotrexate. At drug levels which reduced myelopoiesis, adherent cells proliferated and continued to produce colony stimulating activity. Only at exceptionally high levels (10-3M) did the adherent cell layer fail to support the growth of fresh haemopoietic cells (in vivo toxic plasma concentrations of methotrexate are about 10-8M). Radiation is frequently used as part of the pre-transplant conditioning and it is known from the large volume of work on LTBMC that stromal cells show greater radioresistance than haemopoietic and lymphoid cells. In culture a small percentage (less than 5%) can survive extremely high doses of irradiation (500 Gy) and still produce haemopoietic growth factors.9 The adherent cells after this treatment are a heterogeneous population with two cell types predominating: "a macrophage-like cell and a large flat cell ... a 'blanket' cell". Most show characteristics typical of macrophages (56% phagocytic, 85% acid phosphatase positive, 65% non-specific esterase positive), with 4% alkaline phosphatase positive and 0% factor VIII related antigen positive. If 
